Update on the urotensinergic system: new trends in receptor localization, activation and drug design

Update on the urotensinergic system: new trends in receptor localization, activation and drug design

The urotensinergic system plays central roles in the physiological regulation of major mammalian organ systems, including the cardiovascular system. As a matter of fact, this system has been linked to numerous pathophysiological states including atherosclerosis, heart failure, hypertension, diabetes...

Full description

Bibliographic Details
Main Authors:	David eChatenet, Thi Tuyet Mai eNguyen, Myriam eLetourneau, Alain eFournier
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-01-01
Series:	Frontiers in Endocrinology
Subjects:	Nuclear Receptors urotensin II allosteric modulation Urotensin II-related peptide biased agonist
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00174/full

Similar Items

The Urotensin II System And Carotid Atherosclerosis: A Role In Vascular Calcification
by: Isabella eAlbanese, et al.
Published: (2016-06-01)

The Effect of Silymarin on the Expression of Urotensin–II and Urotensin–II Receptor Genes in the Liver Tissue of Type 2 Diabetic Rats
by: N Kheiripour, et al.
Published: (2019-12-01)

The Effect of Silymarin on the Expression of Urotensin–II and Urotensin–II Receptor Genes in the Liver Tissue of Type 2 Diabetic Rats
by: N Kheiripour, et al.
Published: (2019-04-01)

A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands
by: Roberta d'Emmanuele di Villa Bianca, et al.
Published: (2015-02-01)

Effects of urotensin II receptor antagonist, GSK1440115, in asthma
by: Alison D Portnoy, et al.
Published: (2013-04-01)

Effects of CBD supplementation on ambulatory blood pressure and serum urotensin-II concentrations in Caucasian patients with essential hypertension: A sub-analysis of the HYPER-H21-4 trial
by: Marko Kumric, et al.
Published: (2023-08-01)

Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
by: Ante Mihovilovic, et al.
Published: (2023-05-01)

Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma
by: Vadim Le Joncour, et al.
Published: (2021-04-01)

Dynamic Responses of the Caudal Neurosecretory System (CNSS) Under Thermal Stress in Olive Flounder (Paralichthys olivaceus)
by: Mingzhe Yuan, et al.
Published: (2020-01-01)

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
by: Na Li, et al.
Published: (2022-12-01)

Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients
by: Eray Metin Guler, et al.
Published: (2021-04-01)

The relationship between anxiety and serum urotensin-II and S100B levels in patients with essential hypertension (eng)
by: Aslı Kazğan, et al.
Published: (2021-09-01)

Changes in the electrophysiological parameters of the posterior intestine of Anguilla anguilla (Pisces) induced by oxytocin, urotensin II and aldosterone
by: B. Baldisserotto, et al.
Published: (1997-01-01)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
by: Ibrahim Elmadbouh, et al.
Published: (2017-06-01)

Urotensin II Induces Mice Skeletal Muscle Atrophy Associated with Enhanced Autophagy and Inhibited Irisin Precursor (Fibronectin Type III Domain Containing 5) Expression in Chronic Renal Failure
by: Ya-Jing Pan, et al.
Published: (2019-06-01)

Urotensin II-related peptides, Urp1 and Urp2, control zebrafish spine morphology
by: Elizabeth A Bearce, et al.
Published: (2022-12-01)

Relationship between cardiac rhythm disorders, serum urotensin ІІ and angiotensin ІІ levels in patients with stage ii hypertension and carotid atherosclerosis in dynamics of treatment with candesartan and lercanidipine
by: O. V. Demidenko,, et al.
Published: (2016-10-01)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
by: Marko Simunovic, et al.
Published: (2022-02-01)

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits
by: Qingqing Yu, et al.
Published: (2023-02-01)

Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia
by: Li-Jie Zhang, et al.
Published: (2017-07-01)

Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice
by: Xin-Xin Pang, et al.
Published: (2016-07-01)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in the unanesthethized trout
by: Gilmer eVanegas, et al.
Published: (2015-04-01)

Kidney is in Trouble with Mediators
by: Ayse Balat
Published: (2010-04-01)

Smad2/3 signaling involved in urotensin II-induced phenotypic differentiation, collagen synthesis and migration of rat aortic adventitial fibroblasts
by: Weizhao Lin, et al.
Published: (2023-08-01)

Role of Urotensin-II in Saphenous Vein Graft Disease
by: Mehmet Erin Tüysüz, et al.
Published: (2020-06-01)

Aldosterone is a possible new stimulating factor for promoting vascular calcification
by: Xusheng Zhang, et al.
Published: (2021-11-01)

An investigation of postmortem urotensin II receptor levels in brain and kidney tissues in a rat model of cardiac ischemia
by: Mustafa Talip Sener, et al.
Published: (2018-01-01)

Urotensin II promotes secretion of LTB4 through 5-lipoxygenase via the UT-ROS-Akt pathway in RAW264.7 macrophages
by: Dan Lu, et al.
Published: (2019-05-01)

Features of 24-hour monitoring of blood pressure, serum urotensin II and angiotensin II levels, vascular remodeling and extracranial blood flow in patients with hypertension
by: V. A. Vizir, et al.
Published: (2015-12-01)

The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features
by: Hélène Castel, et al.
Published: (2017-04-01)

Impact of Classic Adrenal Secretagogues on mRNA Levels of Urotensin II and Its Receptor in Adrenal Gland of Rats
by: Karol Jopek, et al.
Published: (2023-08-01)

Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
by: Benjamin Poret, et al.
Published: (2020-03-01)

Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions
by: Turgay Ulas, et al.
Published: (2013-01-01)

Urotensin Ⅱ receptor antagonist(urantide) alleviates renal injury in rats with atherosclerosis
by: LIU Yifei, WANG Xinyu, WANG Jiahui, DU Xiaobing, WANG Tu, ZHAO Juan
Published: (2023-11-01)

Effects of Thymoquinone on Urotensin-II and TGF-β1 Levels in Model of Osteonecrosis in Rats
by: Mehmet Yilmaz, et al.
Published: (2023-10-01)

Conserved role of the urotensin II receptor 4 signalling pathway to control body straightness in a tetrapod
by: Faredin Alejevski, et al.
Published: (2021-08-01)

Inhibition of U‐II/UT signaling ameliorates cystitis‐associated bladder hyperactivity by targeting the RhoA/Rho‐kinase pathway
by: Qian Liu, et al.
Published: (2022-09-01)

Urotensin II promotes the proliferation and secretion of vascular endothelial growth factor in rat dermal papilla cells by activating the Wnt-β-catenin signaling pathway
by: Congjuan Liao, et al.
Published: (2023-06-01)

Effect of urotensin II on apolipoprotein B 100 and apolipoprotein A-I expression in HepG2 cell line
by: Abbas Mohammadi, et al.
Published: (2014-01-01)

The urotensin II receptor antagonist DS37001789 ameliorates mortality in pressure-overload mice with heart failure
by: Mina Nishi, et al.
Published: (2020-02-01)